Abby Green, M.D.  abby.green@wustl.edu

Profile picture
Assistant Professor of Pediatrics, Infectious Diseases
Pathology & ImmunologyInfectious DiseasesHematology and Oncology

phone: (314) 454-6050

Education

  • BA, Tufts University2002
  • MD, New York University School of Medicine2007

Training

  • Resident, Pediatrics, Children's Hospital of Philadelphia2007 - 2010
  • Fellow, Pediatric Infectious Diseases/Pediatric Hematology-Oncology, Children's Hospital of Philadelphia2010 - 2014
  • Post-doctoral fellow, lab of Dr. Matthew Weitzman, Children's Hospital of Philadelphia2014 - 2015

Licensure and Board Certification

  • 2007General Pediatrics, American Board of Pediatrics
  • 2009 - 2021PA, Medical License
  • 2015Hematology-Oncology, American Board of Pediatrics
  • 2015Infectious Diseases, American Board of Pediatrics
  • 2019 - PresMO, Medical Physician and Surgeon

Honors and Awards

  • Eagles Fly for Leukemia Scholar2012 - 2014
  • Selected to attend the 22nd Annual AACR Workshop: Molecular Biology in Clinical Oncology2013
  • Canuso Foundation Innovation Award2014
  • Alex's Lemonade Stand Foundation Young Investigator Award2014 - 2016
  • Translational Research Scholar in Hematologic Malignancies, CHOP Center for Childhood Cancer Research2018
  • Cancer Research Foundation Young Investigator Award2021
  • Virtual Cancer Center Scholar2021

Recent Publications view all (13)


  1. Antiviral Therapeutics in Pediatric Transplant Recipients. Infect Dis Clin North Am. 2022;36(1):125-146. PMCID:PMC8900721  PMID:35168706 
  2. Controllable genome editing with split-engineered base editors Nat Chem Bio. 2021. 
  3. Qualitative and quantitative analysis of DNA-cytidine deaminase activity Methods Mol Biol. 2021. 
  4. Interaction with the CCT chaperonin complex limits APOBEC3A cytidine deaminase cytotoxicity EMBO Rep. 2021;e52145. doi:10.15252/embr.202052145  PMID:34347354 
  5. Fungal infections in children with haematologic malignancies and stem cell transplant recipients Br J Haematol. 2020;189(4):607-624. doi:10.1111/bjh.16452  PMID:32159231  
  6. The spectrum of APOBEC3 activity: From anti-viral agents to anti-cancer opportunities DNA Repair. 2019;83:102700. doi:10.1016/j.dnarep.2019.102700  PMID:31563041  
  7. Interpretation and management of positive anti-hepatitis B core antibody tests in immunocompromised pediatric patients. Transpl Infect Dis. 2019;21(3):e13074. doi:10.1111/tid.13074  PMID:30868720 
  8. Invasive Curvularia Infection in Pediatric Patients With Hematologic Malignancy Identified by Fungal Sequencing. J Pediatric Infect Dis Soc. 2018. PMID:30265347 
  9. Cytosine Deaminase APOBEC3A sensitizes leukemia cells to inhibition of the DNA replication checkpoint. Cancer Res. 2017;77(17):4579-4588. PMCID:5581702   PMID:28655787 
  10. APOBEC3A damages the cellular genome during DNA replication. Cell Cycle. 2016;15(7):998-1008. PMCID:26918916  PMID:26918916  
  11. Utility of unenhanced fat-suppressed T1-weighted MRI in children with sickle cell disease -- can it differentiate bone infarcts from acute osteomyelitis? Pediatr Radiol. 2015;45(13):1981-7. PMID:26209118 
  12. fdg-pet in two cases of neurofibromatosis type 1 and atypical malignancies. Curr Oncol. 2014;21(2):e345-8. PMCID:PMC3997466  PMID:24764718 
  13. An Adolescent With Hepatitis. J Ped Infect Dis. 2012;1(1):81-83. PMID:26618696 
Last updated: 03/29/2022
© 2022 by Washington University in St. Louis
One Brookings Drive, St. Louis, MO 63130